https://chir-265inhibitor.com/....management-of-essent
The long-term time-intervals showed no factor in IOP. After intravitreal injection of a dexamethasone implant, IOP ended up being considerably more than baseline 1 month post-injection. RNFL-thickness was considerably decreased 6 and 12 months post-injection of anti-VEGF, in addition to at end of followup. Caution is advised when working with intravitreal medication, especially when managing clients with advanced glaucoma; in such cases, prophylactic IOP-lowering medication could be conside
Like
Comment
Share
